These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Regulation of normal and neoplastic human mast cell development in mastocytosis. Metcalfe DD Trans Am Clin Climatol Assoc; 2005; 116():185-203; discussion 203-4. PubMed ID: 16555614 [TBL] [Abstract][Full Text] [Related]
3. Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fc epsilon RI- cell population. Rottem M; Okada T; Goff JP; Metcalfe DD Blood; 1994 Oct; 84(8):2489-96. PubMed ID: 7522630 [TBL] [Abstract][Full Text] [Related]
4. Mastocytosis and Mast Cell Activation Disorders: Clearing the Air. Jackson CW; Pratt CM; Rupprecht CP; Pattanaik D; Krishnaswamy G Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681933 [TBL] [Abstract][Full Text] [Related]
5. Targeting c-kit in the therapy of mast cell disorders: current update. El-Agamy DS Eur J Pharmacol; 2012 Sep; 690(1-3):1-3. PubMed ID: 22789565 [TBL] [Abstract][Full Text] [Related]
6. Mastocytosis associated with a rare germline KIT K509I mutation displays a well-differentiated mast cell phenotype. Chan EC; Bai Y; Kirshenbaum AS; Fischer ER; Simakova O; Bandara G; Scott LM; Wisch LB; Cantave D; Carter MC; Lewis JC; Noel P; Maric I; Gilfillan AM; Metcalfe DD; Wilson TM J Allergy Clin Immunol; 2014 Jul; 134(1):178-87. PubMed ID: 24582309 [TBL] [Abstract][Full Text] [Related]
7. Pathogenesis and Pathology of Mastocytosis. Metcalfe DD; Mekori YA Annu Rev Pathol; 2017 Jan; 12():487-514. PubMed ID: 28135563 [TBL] [Abstract][Full Text] [Related]